Nicotinamide Mononucleotide

non-nutrient/non-botanical
Take with food

What is it

Nicotinamide mononucleotide (NMN) is a direct precursor to nicotinamide adenine dinucleotide (NAD+), an essential coenzyme involved in energy metabolism, DNA repair, and cellular signaling. NMN is marketed primarily as a longevity supplement intended to raise declining NAD+ levels with age.

How it works

NMN is converted to NAD+ via the enzyme NMNAT (nicotinamide mononucleotide adenylyltransferase). NAD+ is required for hundreds of cellular reactions, including those catalyzed by sirtuins (SIRT1-7), PARPs (involved in DNA repair), and CD38 (an immune signaling enzyme). Cellular NAD+ levels decline with age, and this decline is implicated in mitochondrial dysfunction, reduced DNA repair, and metabolic decline associated with aging. Oral NMN appears to be absorbed in the small intestine and converted to NAD+ in tissues. The exact mechanism of absorption was debated until the identification of the Slc12a8 transporter for NMN in mice, though its role in humans is still being investigated. Some evidence suggests NMN may be partially broken down to nicotinamide riboside (NR) in the gut before absorption, then reconverted to NMN intracellularly. NMN raises NAD+ levels in animal studies and several small human studies. Whether higher NAD+ levels achieved through supplementation produce meaningful clinical benefits in humans is still being investigated.

Evidence for 6 uses

AI-assisted evidence assessment — talk to your doctor before relying on any single supplement.

Raising NAD+ levels

Grade B

Good evidence

Multiple small human trials have shown oral NMN reliably increases blood NAD+ levels in a dose-dependent manner. This is the most consistently supported effect of NMN supplementation.

Physical function in older adults

Grade C

Moderate evidence

Small clinical trials suggest possible improvements in measures such as walking speed and grip strength in older adults with NMN supplementation. Evidence is preliminary and effect sizes are small.

Aerobic capacity / exercise performance

Grade C

Moderate evidence

A few small studies in middle-aged or older adults suggest NMN may modestly improve aerobic capacity (VO2 max) and muscle function. Evidence is limited.

Insulin sensitivity

Grade C

Moderate evidence

A study in postmenopausal women with prediabetes showed NMN improved insulin sensitivity. Other small trials have not consistently replicated metabolic benefits.

Longevity / healthspan

Grade F

Limited evidence

Despite extensive preclinical interest and rodent data, there is no human evidence that NMN extends lifespan or healthspan. Claims linking it to longevity are extrapolations from animal studies.

Cognitive function

Grade F

Limited evidence

Mechanistic interest exists, but human evidence for cognitive improvements is essentially absent.

3 commercial forms

Standard NMN powder/capsule

Most common form; absorbed orally in the small intestine.

Available in capsules and powder. Quality control varies widely; third-party testing is recommended.

Sublingual NMN

Absorbed through oral mucosa, potentially bypassing some first-pass metabolism.

May offer faster onset and modest bioavailability advantages.

Liposomal NMN

Phospholipid encapsulation for improved stability and absorption.

Higher cost; bioavailability claims often outpace clinical evidence.

Dosage

There is no RDA for NMN. Most human studies have used 250 to 1,000 mg per day, with 250 to 500 mg being typical in consumer products. Higher doses (1,200 mg) have been studied but do not clearly offer more benefit. Effects on NAD+ levels typically appear within weeks of consistent supplementation.

When and how to take it

WHEN: Most user routines take NMN in the morning on an empty stomach or with breakfast. There is no strong evidence for a specific optimal time. Some sources recommend morning dosing based on circadian variation of NAD+ pathways. HOW: Take with water; sublingual forms should be held under the tongue for 30 to 60 seconds. Liposomal or sublingual forms may offer modest absorption advantages. Splitting doses is unnecessary for most users.

Food sources

FoodAmount%DV
Broccoli1 cup
Cabbage1 cup
Cucumber1 cup
Edamame1/2 cup
Avocado1/2 medium
Tomato1 medium

Safety

NMN appears generally well tolerated in short-term human studies. Mild side effects reported include nausea, indigestion, headache, and flushing. There is no established Tolerable Upper Intake Level. Long-term safety beyond 12 weeks is not well characterized in humans. In late 2022, the FDA stated that NMN was being investigated as a drug and excluded from the dietary supplement definition, creating regulatory uncertainty for products marketed in the US.

Who should be cautious

Pregnant and breastfeeding women should avoid NMN supplementation due to absence of safety data. People with active cancer should consult their oncologist; NAD+ and sirtuin pathways are involved in both protective and proliferative cellular responses. Those on chemotherapy regimens, particularly PARP inhibitors, should not use NMN without medical supervision. The long-term effects on cancer risk in healthy people are unknown.

Interactions

Specific clinically significant drug interactions with NMN are not well documented. Theoretically, NMN's effects on NAD+ and sirtuin pathways could interact with chemotherapy drugs targeting NAD+ metabolism (such as PARP inhibitors). Effects on metabolism and immune function are theoretical concerns without solid human data.

Frequently asked questions

Does NMN actually slow aging?

NMN raises NAD+ levels and shows lifespan effects in rodents. Whether it slows aging or extends life in humans has not been demonstrated. Claims linking NMN to longevity in humans are speculative.

What's the difference between NMN and NR?

Both are NAD+ precursors. NMN is one step closer to NAD+ in the biosynthesis pathway, but NR appears to enter cells more readily in most tissues. Clinical effects between the two are largely similar in available studies.

Is NMN still legal to sell in the US?

As of late 2022, the FDA took the position that NMN was being investigated as a drug and excluded from the dietary supplement definition. Regulatory and legal status remains in flux; check current guidance before purchasing.

How long until I see benefits?

Blood NAD+ levels typically rise within a few weeks. Subjective effects, when they occur, are variable. Most clinical trials run 8 to 12 weeks.

Is NMN safe long-term?

Short-term human safety appears acceptable. Long-term human safety data are limited. Theoretical concerns about effects on cancer cell proliferation exist but are unresolved.

References

  • Wikidata: NMNWikidata link
  • PubChem: NMN (CID 6093202)PubChem link

Track Nicotinamide Mononucleotide with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.

Coming to App Store

Disclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments — talk to your doctor before starting any new supplement, especially if you're pregnant, breastfeeding, on medications, or managing a chronic condition.